We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aviva Plc | LSE:AV. | London | Ordinary Share | GB00BPQY8M80 | ORD 32 17/19P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.90 | -0.60% | 477.90 | 478.90 | 479.10 | 482.00 | 476.50 | 481.50 | 9,681,845 | 16:35:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Insurance Carriers, Nec | 41.43B | 1.09B | 0.3962 | 12.09 | 13.12B |
Date | Subject | Author | Discuss |
---|---|---|---|
09/1/2021 13:13 | Thank you DR B. | ianood | |
09/1/2021 12:49 | Good news, looks like my latest purchase at 4:27 PM yesterday may have been well timed. Also in the news(The Times) new government in America is looking to inject $3.7 Trillion (yes trillion) into the economy to get it moving forward. This may be seen positive by markets in USA and here. Roll on Monday, fully invested here. | whatsup32 | |
09/1/2021 12:33 | Initial estimates were for 2.5-3bn so this would be a decent sale. Will be interesting to see if anything pops up in the uk press tomorrow | dr biotech | |
09/1/2021 11:31 | Think that the market will like this offer good to see a bidder has thrown their hat in the ring at a respectable price. | wskill | |
09/1/2021 11:25 | I thought own funds for France was £3bln - with all the messy stuff in here and unions and difficult regulators I’d take own funds all day long | cjac39 | |
09/1/2021 11:22 | Think that this will be within the expectation around 5 or 6 times annual profit more or less what Aviva commands. I would have hoped for a decent sort of bid premium there is time yet for another bidder to increase this . | wskill | |
09/1/2021 11:04 | Do people think €3.2B is acceptable? Will this be viewed well by the market? | carpingtris | |
09/1/2021 10:26 | Thanks Dr Biotech. | skinny | |
09/1/2021 10:22 | It is quite a leak, if the article is correct the journal has found out before Aviva has as the article was published yesterday at 7pm... | dr biotech | |
09/1/2021 09:48 | Surely, such a detailed 'leak' will necesitate a Statement by Aviva on Monday. | 1robbob | |
09/1/2021 09:42 | Thanks for posting, much appreciated. | 10acious | |
09/1/2021 09:37 | thats quite a detailed leak. i suspect they are trying to gain momentum with the other stakeholders like unions behind their bid... | cjac39 | |
09/1/2021 06:22 | Is this correct translation? Tabled a bid of 3.2Bn , and at end of 2019 Macif had equity of same amount...WTF ? | mountpleasant | |
09/1/2021 00:43 | Apparently an offer forAviva France has been tabled today at 3.2 Billion euros ( according to a French source) | salver2 | |
09/1/2021 00:40 | If an (ex special div.) share price price of 330p with a yield of 6.25% materialises, my strategy would unhesitatingly be to plough the whole 75/100p back into topping up my holding in Aviva. | imagining | |
08/1/2021 22:41 | ah ok, my mistake. | karv1 | |
08/1/2021 22:13 | Rob when /if this was to happen I think the 430 would be a spike until the payment and this would drop back down to somewhere lower due to the 21p dividend. Because at 430+ this would make this below 5% dividend. The 21p will act as a cap for the share price. It would drop until the dividend found the balance with the likes of LGEN in my view. The 2 ways this will stay at 430 is if the whole market goes up and all returns get lower as a percentage or they pay out the extra cash slowly which will cause a yoyo effect. If I was holding before the special I would either sell on the build-up to special payment or just after payment and stick it in Lgen for 6.5% or national grid for 5.5% or someone else. On the positive side, an extra 75/100p would be amazing at the current share price. | karv1 | |
08/1/2021 20:55 | What will the markets' reaction be when AB announces that as a result of asset sales between 75p and 100p per share will be returned to shareholders as a special dividend AND that the annual ordinary dividend of 21p per share will be maintained My guess = 430p | 1robbob | |
08/1/2021 20:50 | Quite a common Norwegian name. | dbadvn | |
08/1/2021 20:35 | I just have and he’s a second contact of mine so I’ve invited him to connect. Great name | cjac39 | |
08/1/2021 19:16 | No. You can look him up on Linkedin. You can imagine the adaptations (although I knew him from working with him and his McKinsey group in Munich, and the name only worked for us Anglos). | wba1 | |
08/1/2021 18:13 | I have not looked at them although, oddly (pun), I know their Oslo claims head Odd Magnus Barstad from his McKinsey days. I don't recall that big a company hitting such a COR, although smaller niche operations do (including Sabre in the UK). It does seem that the Scandinavian markets offer better returns than elsewhere, as the RSA operations also performed very well and are the foundation of the price being paid for RSA. | wba1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions